Rationale, Criteria, and Impact of Identifying Extreme Risk in Patients with Atherosclerotic Cardiovascular Disease

Rationale, Criteria, and Impact of Identifying Extreme Risk in Patients with Atherosclerotic Cardiovascular Disease

Abstract. Assessment of the overall risk of atherosclerotic cardiovascular disease (ASCVD) is the first step in managing dyslipidemia and is an important reference for the target and intensity of treatment. Recently, different guidelines and consensuses on the management of this condition have succe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuhong Zeng, Dong Zhao, Tianyu Xu, Xiaoxia Fu
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2022-06-01
Series:	Cardiology Discovery
Online Access:	http://journals.lww.com/10.1097/CD9.0000000000000053
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease
by: Xi Li, et al.
Published: (2025-02-01)

CLINICAL AND ECONOMICAL RATIONALES OF CARDIOVASCULAR RISK EVALUATION AT WORKPLACE
by: A. V. Kontsevaya, et al.
Published: (2016-01-01)

Advancements in research to mitigate residual risk of atherosclerotic cardiovascular disease
by: Fan Shi, et al.
Published: (2025-08-01)

Pregnancy-Induced Hypertension and Atherosclerotic Cardiovascular Disease Risk Score in China
by: Honghong He, MM, et al.
Published: (2025-04-01)

Non-traditional lipid biomarkers in atherosclerotic cardiovascular disease: pathophysiological mechanisms and strategies to address residual risk
by: Cong Wang, et al.
Published: (2025-07-01)

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases: Time to Start Better Cardiovascular Primary Prevention
by: Guang Ning, et al.
Published: (2021-06-01)

The Effects of Inclisiran on the Subclinical Inflammatory Markers of Atherosclerotic Cardiovascular Disease in Patients at High Cardiovascular Risk
by: Mateusz Maligłówka, et al.
Published: (2025-06-01)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021-05-01)

Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study
by: Jonica Campolo, et al.
Published: (2024-07-01)

Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.
by: Yiyi Zhang, et al.
Published: (2024-01-01)

Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk
by: Omar M. El-Rakabawy, et al.
Published: (2025-08-01)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
by: Charles Amir German, et al.
Published: (2020-07-01)

Association of glucose to lymphocyte ratio with the risk of death in patients with atherosclerotic cardiovascular disease
by: Jinglin Lei, et al.
Published: (2025-01-01)

Present and Future Perspectives on the Role of Biomarkers in Atherosclerotic Cardiovascular Disease Risk Stratification
by: Bruna Gigante
Published: (2023-04-01)

Evaluation of 10 Years Atherosclerotic Cardiovascular Risk, Vitamin D and Metabolic Profiles in Smokers
by: Mehrdad Simani, et al.
Published: (2025-01-01)

Genetic Susceptibility to Type 2 Diabetes, Television Viewing, and Atherosclerotic Cardiovascular Disease Risk
by: Mengyao Wang, et al.
Published: (2025-03-01)

Rationale and Design of a Randomized Controlled Trial on Intensive Management of Blood PRESSure and Cholesterol in Elderly Chinese with Hypertension and Atrial FibrillatION (IMPRESSION)
by: Wei Zhang, et al.
Published: (2021-09-01)

Atherosclerotic plaque in carotid arteries as a risk marker for cardiovascular events risk in middle aged population
by: A. I. Ershova, et al.
Published: (2018-08-01)

Amino Acid Metabolism and Autophagy in Atherosclerotic Cardiovascular Disease
by: Yuting Wu, et al.
Published: (2024-12-01)

Single-Cell Sequencing of the Cardiovascular System: Challenges in Translation
by: Zheng Li, et al.
Published: (2021-09-01)

Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10‐Year Atherosclerotic Cardiovascular Risk Prediction
by: Hui Zhou, et al.
Published: (2025-02-01)

Associations of serum uric acid, risk of atherosclerotic cardiovascular disease, and mortality: results from NHANES
by: Rundong Chen, et al.
Published: (2025-04-01)

Vascular Smooth Muscle Cell Development and Cardiovascular Malformations
by: Lihua Qi, et al.
Published: (2021-12-01)

An Electronic, Preclinic, Social Determinants Survey Shows Pediatric Atherosclerotic Risk Factor Referral Identifies At-Risk Families
by: Justin R. Rahman, MHA, et al.
Published: (2025-06-01)

Integrated solution for very high cardiovascular risk patients. Rationale and design of a pilot study
by: E. I. Pavlyuk, et al.
Published: (2021-08-01)

Incidence and risk factors regarding atherosclerotic cardiovascular disease in middle-aged and elderly people with HIV treated in Chongqing, China
by: Min Liu, et al.
Published: (2024-12-01)

BMI-mediated association between glyphosate exposure and increased risk of atherosclerotic heart disease: A large-scale cross-sectional study.
by: Wendi Xu, et al.
Published: (2025-01-01)

Could erectile dysfunction be a marker of atherosclerotic cardiovascular disease?
by: G. G. Sharvadze, et al.
Published: (1970-01-01)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
by: Kengo Sato, et al.
Published: (2013-01-01)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
by: Erdinç Hatipsoylu, et al.
Published: (2019-09-01)

COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases
by: Yuanyuan Zhang, et al.
Published: (2021-12-01)

Implementing the Guideline of the Primary Prevention of Cardiovascular Diseases in China to Daily Practice: Promoting the Transition from “Treatment-Centered” to “People's Health-Centered”
by: Dayi Hu, et al.
Published: (2021-06-01)

Effects of Omega-3 Fatty Acids on Chinese Patients with Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis
by: Zhu Mei, et al.
Published: (2022-03-01)

Development and Validation of Models to Estimate the Incident Risk of Cognitive Impairment and Atherosclerotic Cardiovascular Disease in Older Adults
by: Michael G. Nanna, et al.
Published: (2025-06-01)

Genomic and Precision Medicine Approaches in Atherosclerotic Cardiovascular Disease: From Risk Prediction to Therapy—A Review
by: Andreas Mitsis, et al.
Published: (2025-07-01)

Comparison of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in metropolitan and rural areas of South of Iran
by: Mohammad Javad Zibaeenezhad, et al.
Published: (2025-01-01)

Novel lipid profiles and atherosclerotic cardiovascular disease risk: insights from a latent profile analysis
by: Hongli Wan, et al.
Published: (2025-02-01)

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND ORAL HEALTH: PATHOPHYSIOLOGICAL LINKS AND CLINICAL IMPLICATIONS
by: Luiza Camelia Nechita, et al.
Published: (2025-03-01)

Obesity and Atherosclerotic Cardiovascular Disease: A Review of Social and Biobehavioral Pathways
by: Izza Shahid, et al.
Published: (2025-02-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)